Parkinson’s | Xconomy

by in

Entry	Blogger	Date	Location
Faster, Cheaper Stem Cells: Fate Therapeutics Co-Founder, With Scripps Team, Finds Key	Luke Timmerman	10/18/09	National
Omeros, First U.S. Biotech IPO Since February 2008, Sees Shares Drop 13 Percent in First Day	Luke Timmerman	10/08/09	Seattle
Avanir’s Results for Neurological Drug Triggers Outburst in Trading	Bruce V. Bigelow	08/11/09	San Diego
Targeted Genetics Faces Extinction, Cell Therapeutics Unloads Debt, Dendreon Raises $221M, & More Seattle-Area Life Sciences News	Luke Timmerman	05/14/09	Seattle
ProteoTech Raises $519K	Luke Timmerman	05/11/09	Seattle
Acadia Shares Soar on Alliance With Biovail for Parkinson’s Psychosis Drug	Luke Timmerman	05/04/09	San Diego
Biogen Idec Parkinson’s Drug Hits Goal in Pair of Mid-Stage Trials	Luke Timmerman	01/13/09	Boston
Omeros Nabs Michael J. Fox Grant	Luke Timmerman	01/07/09	Seattle
Biogen Idec Takes Aim at New Parkinson’s Paradigm	Luke Timmerman	01/05/09	Boston
Ceregene Drug Fails in Parkinson’s Trial	Luke Timmerman	12/01/08	San Diego
Sirtris’ Red Wine Chemical to Take Back Seat to “Potent” Diabetes Drugs	Ryan McBride	10/23/08	Boston
Link Medicine Raises $40 Million to Counter Neurodegenerative Disease	Wade Roush	09/30/08	Boston
Proteostasis Eyes Technique to Keep Your Proteins in Balance	Luke Timmerman	09/15/08	Boston
Page 1 of 1

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.